Saptarshi Roy

1.2k total citations
28 papers, 792 citations indexed

About

Saptarshi Roy is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Saptarshi Roy has authored 28 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Saptarshi Roy's work include Mast cells and histamine (11 papers), Research on Leishmaniasis Studies (7 papers) and Asthma and respiratory diseases (5 papers). Saptarshi Roy is often cited by papers focused on Mast cells and histamine (11 papers), Research on Leishmaniasis Studies (7 papers) and Asthma and respiratory diseases (5 papers). Saptarshi Roy collaborates with scholars based in United States, India and Saudi Arabia. Saptarshi Roy's co-authors include Hydar Ali, Chalatip Chompunud Na Ayudhya, Chitra Mandal, Vishwa Deepak, G. Aditya Kumar, Md. Jafurulla, Amitabha Chattopadhyay, Carole A. Oskeritzian, Biswajit Khatua and Magda Babina and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Saptarshi Roy

28 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saptarshi Roy United States 19 410 236 205 138 131 28 792
Yasushi Takamori Japan 7 483 1.2× 284 1.2× 459 2.2× 147 1.1× 120 0.9× 9 1.2k
Clinton B. Mathias United States 16 566 1.4× 214 0.9× 395 1.9× 430 3.1× 107 0.8× 34 1.2k
Yasuaki Shimizu Japan 21 160 0.4× 359 1.5× 262 1.3× 36 0.3× 55 0.4× 39 901
Shân L. Gyles United Kingdom 9 148 0.4× 197 0.8× 236 1.2× 65 0.5× 48 0.4× 11 613
E. Angel Jemima India 6 210 0.5× 129 0.5× 136 0.7× 121 0.9× 60 0.5× 14 474
S Yoshida Japan 13 185 0.5× 159 0.7× 265 1.3× 97 0.7× 46 0.4× 26 682
Anthony L. Schwartz United States 17 480 1.2× 218 0.9× 113 0.6× 44 0.3× 15 0.1× 30 792
Kitti Pázmándi Hungary 17 347 0.8× 217 0.9× 82 0.4× 45 0.3× 26 0.2× 36 701
Linda L. Walker United States 16 394 1.0× 326 1.4× 210 1.0× 74 0.5× 47 0.4× 24 958
Gabriela Kukova Germany 7 145 0.4× 63 0.3× 198 1.0× 264 1.9× 147 1.1× 13 787

Countries citing papers authored by Saptarshi Roy

Since Specialization
Citations

This map shows the geographic impact of Saptarshi Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saptarshi Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saptarshi Roy more than expected).

Fields of papers citing papers by Saptarshi Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saptarshi Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saptarshi Roy. The network helps show where Saptarshi Roy may publish in the future.

Co-authorship network of co-authors of Saptarshi Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Saptarshi Roy. A scholar is included among the top collaborators of Saptarshi Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saptarshi Roy. Saptarshi Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Saptarshi, et al.. (2025). Dysfunctional β-cell autophagy induces β-cell stress and enhances islet immunogenicity. Frontiers in Immunology. 16. 1504583–1504583. 4 indexed citations
2.
Moran, James, et al.. (2025). Impact of Persistent Endocrine-Disrupting Chemicals on Human Nuclear Receptors: Insights from In Silico and Experimental Characterization. International Journal of Molecular Sciences. 26(7). 2879–2879. 3 indexed citations
3.
Roy, Saptarshi, et al.. (2024). MRGPRX2 facilitates IgE-mediated systemic anaphylaxis in a newly established knock-in mouse model. Journal of Allergy and Clinical Immunology. 155(3). 974–987.e1. 4 indexed citations
4.
Roy, Saptarshi, Zhiwei Xu, Carmella Evans‐Molina, et al.. (2024). Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of type 1 diabetes. Diabetologia. 68(2). 382–396. 3 indexed citations
5.
Roy, Saptarshi, et al.. (2024). Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors. International Journal of Molecular Sciences. 25(15). 8241–8241. 9 indexed citations
6.
Ayudhya, Chalatip Chompunud Na, et al.. (2021). Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases. Current Allergy and Asthma Reports. 21(1). 3–3. 61 indexed citations
7.
Roy, Saptarshi, et al.. (2021). Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease. Journal of Allergy and Clinical Immunology. 148(2). 293–308. 114 indexed citations
8.
Ayudhya, Chalatip Chompunud Na, et al.. (2020). Roles of a Mast Cell–Specific Receptor MRGPRX2 in Host Defense and Inflammation. Journal of Dental Research. 99(8). 882–890. 30 indexed citations
9.
Roy, Saptarshi, et al.. (2019). Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B2 Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast Cells. The Journal of Immunology. 202(4). 1229–1238. 39 indexed citations
10.
11.
Roy, Saptarshi, et al.. (2019). Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in Leishmania donovani Infected Macrophages. Frontiers in Immunology. 10. 2360–2360. 30 indexed citations
12.
13.
Roy, Saptarshi, et al.. (2017). Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis. Scientific Reports. 7(1). 4141–4141. 34 indexed citations
14.
Kumar, G. Aditya, Saptarshi Roy, Md. Jafurulla, Chitra Mandal, & Amitabha Chattopadhyay. (2016). Statin-induced chronic cholesterol depletion inhibits Leishmania donovani infection: Relevance of optimum host membrane cholesterol. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(9). 2088–2096. 29 indexed citations
15.
Mandal, Abhishek, Sushmita Das, Saptarshi Roy, et al.. (2016). Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway. PLoS neglected tropical diseases. 10(1). e0004373–e0004373. 37 indexed citations
16.
Roy, Saptarshi, G. Aditya Kumar, Md. Jafurulla, Chitra Mandal, & Amitabha Chattopadhyay. (2014). Integrity of the Actin Cytoskeleton of Host Macrophages is Essential for Leishmania donovani Infection. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1838(8). 2011–2018. 37 indexed citations
17.
Khatua, Biswajit, Saptarshi Roy, & Chitra Mandal. (2013). Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.. PubMed. 138(5). 648–62. 25 indexed citations
18.
Mondal, Susmita, Saptarshi Roy, Asish Mallick, et al.. (2012). RETRACTED CHAPTER: Withanolide D, Carrying the Baton of Indian Rasayana Herb as a Lead Candidate of Antileukemic Agent in Modern Medicine. Advances in experimental medicine and biology. 749. 295–312. 10 indexed citations
19.
Roy, Saptarshi, Asish Mallick, Vishal Soni, et al.. (2011). Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice. Vaccine. 30(6). 1083–1093. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Takamori Breakdown of academic impact, for papers by Clinton B. Mathias Breakdown of academic impact, for papers by Yasuaki Shimizu Breakdown of academic impact, for papers by Shân L. Gyles Breakdown of academic impact, for papers by E. Angel Jemima Breakdown of academic impact, for papers by S Yoshida Breakdown of academic impact, for papers by Anthony L. Schwartz Breakdown of academic impact, for papers by Kitti Pázmándi Breakdown of academic impact, for papers by Linda L. Walker Breakdown of academic impact, for papers by Gabriela Kukova
Rankless by CCL
2026